Studying the Effectiveness of Early Invasive Treatment in Elderly Patients With High-risk Non-ST-segment Elevation Acute Coronary Syndrome.

Gia Dinh People Hospital

Status: Enrolling

Conditions: Myocardial Infarction

Study type: Observational

Funder types: Other

Identifiers

NCT06486233

329/HDDD-DHYD

Details and patient eligibility

About

The goal of this is observational study is to compare about MACE events and predisposing factors related to MACE events in elderly patients with high-risk non-ST acute coronary syndromes receiving early versus late invasive treatment . This study will anwser two questions.

Question 1: What will factors associate with implementing a late invasive strategy in elderly patients with high-risk non-ST-segment elevation acute coronary syndrome ? Question 2: Is a meaningful difference about mortality and complication rates as re-myocardial infarction, heart failure, re-hospitalization, stroke after 12 months between two groups of patients undergoing early invasive and late invasive strategies in elderly patients with in high-risk non-ST-segment elevation acute coronary syndrome?

Enrollment: 385 estimated patients

Sex: All

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• aged 60 years and older
• high - risk non-ST-segment elevation acute coronary syndrome (according to the 2023 European Heart Association recommended standards).
• receives reperfusion intervention.

Exclusion criteria

• Acute coronary syndrome due to stent thrombosis, or coronary artery bypass graft occlusion.
• Incomplete medical records.

Trial design

385 participants in 2 patient groups

Observe the patient with early percutaneous coronary intervention

Description:

Elderly patients with non-ST-segment elevation acute coronary syndrome receive early percutaneous coronary intervention (\< 24 hours after diagnosis).

Observe the patient with late percutaneous coronary intervention

Description:

Elderly patients with non-ST elevation acute coronary syndrome undergoing late percutaneous coronary intervention (≥ 24 hours after diagnosis)